Table 5. Comparison of demographics and relevant comorbidities between patients with normal sweat output on QSART and patients with reduced sweat output on QSART.
Normal sweat output (n = 141) | Abnormal sweat output (n = 70) | p-value | |
Age (years) | 31 ± 10 | 33 ± 12 | 0.16 |
Percent female | 95% | 90% | 0.24 |
%White | 93% | 90% | 0.71 |
Symptom duration (years) | 5 (4, 6) | 5 (4, 6) | 0.69 |
Comorbidities | |||
Autoimmune disease (celiac, Hashimoto’s, RA, Sjogren’s) | 11% | 20% | 0.10 |
Chiari | 5% | 0% | 0.10 |
Ehlers-Danlos/Joint hypermobility | 18% | 20% | 0.85 |
Fibromyalgia | 22% | 20% | 0.86 |
Migraine | 52% | 50% | 0.88 |
Raynaud’s | 14% | 13% | 1 |